← Evidence map

ArticlePituitary2024

When to decide on testosterone replacement despite dopamine agonist therapy in male prolactinomas?

Hidenori FukuokaPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39287884